Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Efficacy and Safety of Transcranial Magnetic Stimulation Targeting Cerebellum to Treat Drug-resistant Epilepsy During Enhanced and Maintenance Phase

NCT06832813 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06832813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06832813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Efficacy and Safety of Transcranial Magnetic Stimulation Targeting Cerebellum to Treat Drug-resistant Epilepsy During Enhanced and Maintenance Phase
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 28, 2025
Completion date
March 27, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug-resistant epilepsy, transcranial magnetic stimulation